Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today reported second quarter 2026 U.S. GAAP diluted earnings per share of $1.15 and adjusted earnings per share of $2.45. Net sales of $2.8 billion increased 18 percent sequentially, reflecting a 4 percent increase in volume and a 14 percent increase in price. Results were driven by strong execution across both businesses, including favorable pricing and mix outcomes in Engineered Materials and strong commercial and operational execution within the Acetyl Chain. The quarter also benefited from continued momentum across targeted growth platforms, particularly in medical and electronics.
Celanese leveraged the flexibility of its global manufacturing and supply chain networks to capitalize on rapidly evolving market conditions while continuing to advance actions designed to improve the competitiveness, resilience, and earnings power of the portfolio. For the second quarter, the Company reported consolidated operating profit of $276 million, adjusted EBIT of $470 million, and operating EBITDA of $649 million at margins of 10, 17, and 24 percent, respectively.
During the quarter, Celanese continued to execute against its strategic priorities of driving growth, intensifying cost improvements, and strengthening cash generation to support deleveraging. Actions included completion of the Ulsan, South Korea Engineered Materials compounding unit closure, completion of the nylon 6,6 manufacturing network optimization ahead of schedule, and continued progress toward the planned closure of the acetate tow facility in Lanaken, Belgium. Together, these initiatives are expected to deliver in excess of $50 million of annualized fixed-cost savings while improving the long-term competitiveness of the portfolio.
"The second quarter demonstrated the agility and focus of Celanese and the benefits of the actions we are taking across both businesses," said Scott Richardson, president and chief executive officer. "We delivered our highest adjusted earnings per share in nearly three years through commercial execution, continued progress in our growth initiatives, and the effectiveness of our global manufacturing and supply chain networks. At the same time, we advanced important portfolio, productivity, and footprint actions that are improving competitiveness, strengthening cash generation, supporting deleveraging, and positioning Celanese for continued earnings growth."
Second Quarter 2026 Financial Highlights:
|
Three Months Ended |
||||||||||
|
June 30,
|
|
March 31,
|
|
June 30,
|
||||||
|
(unaudited) |
||||||||||
|
(In $ millions, except per share data) |
||||||||||
Net Sales |
|
|
|
|
|
||||||
Engineered Materials |
|
1,446 |
|
|
|
1,325 |
|
|
|
1,442 |
|
Acetyl Chain |
|
1,329 |
|
|
|
1,036 |
|
|
|
1,115 |
|
Intersegment Eliminations |
|
(23 |
) |
|
|
(24 |
) |
|
|
(25 |
) |
Total |
|
2,752 |
|
|
|
2,337 |
|
|
|
2,532 |
|
|
|
|
|
|
|
||||||
Operating Profit (Loss) |
|
|
|
|
|
||||||
Engineered Materials |
|
156 |
|
|
|
221 |
|
|
|
164 |
|
Acetyl Chain |
|
237 |
|
|
|
95 |
|
|
|
153 |
|
Other Activities |
|
(117 |
) |
|
|
(102 |
) |
|
|
(86 |
) |
Total |
|
276 |
|
|
|
214 |
|
|
|
231 |
|
|
|
|
|
|
|
||||||
Net Earnings (Loss) |
|
129 |
|
|
|
48 |
|
|
|
200 |
|
|
|
|
|
|
|
||||||
Adjusted EBIT(1) |
|
|
|
|
|
||||||
Engineered Materials |
|
234 |
|
|
|
220 |
|
|
|
213 |
|
Acetyl Chain |
|
321 |
|
|
|
131 |
|
|
|
195 |
|
Other Activities |
|
(85 |
) |
|
|
(76 |
) |
|
|
(66 |
) |
Total |
|
470 |
|
|
|
275 |
|
|
|
342 |
|
|
|
|
|
|
|
||||||
Equity Earnings and Dividend Income |
|
|
|
|
|
||||||
Engineered Materials |
|
6 |
|
|
|
31 |
|
|
|
24 |
|
Acetyl Chain |
|
44 |
|
|
|
2 |
|
|
|
43 |
|
|
|
|
|
|
|
||||||
Operating EBITDA(1) |
|
649 |
|
|
|
455 |
|
|
|
530 |
|
Diluted EPS - continuing operations |
$ |
1.15 |
|
|
$ |
0.41 |
|
|
$ |
1.89 |
|
Diluted EPS - total |
$ |
1.13 |
|
|
$ |
0.40 |
|
|
$ |
1.80 |
|
Adjusted EPS(1) |
$ |
2.45 |
|
|
$ |
0.85 |
|
|
$ |
1.43 |
|
|
|
|
|
|
|
||||||
Net cash provided by (used in) investing activities |
|
(59 |
) |
|
|
425 |
|
|
|
(88 |
) |
Net cash provided by (used in) financing activities |
|
(546 |
) |
|
|
(3 |
) |
|
|
(116 |
) |
Net cash provided by (used in) operating activities |
|
209 |
|
|
|
76 |
|
|
|
410 |
|
Free cash flow(1) |
|
140 |
|
|
|
3 |
|
|
|
311 |
|
________________________ |
|
(1) |
See "Non-US GAAP Financial Measures" below. |
Recent Highlights:
Second Quarter Business Segment Overview
Engineered Materials
Engineered Materials reported second quarter net sales of $1.45 billion, a 9 percent sequential increase, consisting of a 3 percent increase in volume, a 6 percent increase in pricing, and a modest currency benefit. Results were driven by strong commercial execution, favorable pricing and mix, and continued momentum across strategic growth platforms, particularly in medical and electronics. The business reported second quarter operating profit of $156 million, adjusted EBIT of $234 million, and operating EBITDA of $335 million, with margins of 11, 16, and 23 percent, respectively. Performance benefited from improving portfolio mix, targeted growth initiatives, and ongoing execution of the Engineered Materials Grow & Fortify strategy. During the quarter, the business completed the previously announced Ulsan, South Korea compounding unit closure and nylon 6,6 network optimization ahead of schedule, as well as the successful execution of the business's largest POM turnaround in five years. Collectively, these actions strengthen the business' competitiveness, flexibility, and participation in higher-growth end markets.
Acetyl Chain
The Acetyl Chain reported second quarter net sales of $1.33 billion, a 28 percent sequential increase, consisting of increases of 6 percent in volume and 22 percent in price, with a small currency benefit. Results reflected the successful capture of pricing and margin opportunities and volume gains in the Western Hemisphere driven by Celanese's position as a reliable supplier via the business's integrated global network. The business delivered second quarter operating profit of $237 million, adjusted EBIT of $321 million, and operating EBITDA of $385 million at margins of 18, 24, and 29 percent, respectively. Performance highlighted the flexibility of the Acetyl Chain business model, as the Company leveraged its integrated global network, reliability of supply, and commercial agility to capture opportunities and strengthen customer relationships. During the quarter, Celanese completed the rapid restart of the Frankfurt VAM unit, optimized network utilization, and continued advancing downstream growth initiatives and productivity actions designed to improve the durability and earnings profile of the business.
Cash Flow and Tax
Celanese reported second quarter operating cash flow of $209 million and free cash flow of $140 million. Cash generation in the quarter reflected timing effects of working capital associated with the higher sales and earnings profile. Capital expenditures remained disciplined and aligned with the Company's deleveraging priorities.
The effective U.S. GAAP income tax rate was 8 percent, reflecting the impact of discrete items occurring during the second quarter, which was higher compared to the same period in 2025, primarily due to non-recurring favorable tax items for changes in uncertain tax positions related to prior year tax examinations and deferred tax benefits related to integration transactions in the prior year. The effective tax rate for 2026 adjusted earnings was also 8 percent for the second quarter, and we anticipate this rate for the full year 2026 based on expected jurisdictional earnings mix for the full year and consideration of other non-recurring U.S. GAAP items.
Outlook
"Looking to the third quarter, we expect continued moderation of supply-related opportunities, along with the impact of higher raw material costs in Engineered Materials and inventory-related actions associated with our nylon 6,6 and Lanaken footprint optimizations," continued Richardson. "Based on these dynamics, we expect third quarter adjusted earnings per share of approximately $1.35 to $1.75."
"While earnings are expected to moderate from the strong second quarter level, we remain focused on executing the initiatives within our control and continue to expect approximately $6.00 of adjusted earnings per share and $700 to $800 million of free cash flow for the full year. In the second quarter, we saw early benefits of our growth strategy and the increasing contribution of our growth platforms. Together with our productivity, portfolio, and footprint actions, these initiatives position Celanese to deliver strong performance in 2026 and create additional earnings growth opportunities in the years ahead," Richardson concluded.
Reconciliations of forecasted non-GAAP measures such as adjusted earnings per share, adjusted EBIT, operating EBITDA or free cash flow to the equivalent U.S. GAAP measures (diluted earnings per share, net earnings (loss) attributable to Celanese Corporation and net cash provided by (used in) operations, respectively), are not available without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, and other items is not practical. For more information, see "Non-GAAP Financial Measures" below.
The Company's prepared remarks related to the second quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library on August 4, 2026. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our investor relations website under Financial Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures" below.
Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs more than 11,000 employees worldwide with 2025 net sales of $9.5 billion.
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the ability to successfully achieve planned cost reductions; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness and our financial condition, each of which could diminish our ability to raise additional capital to fund operations, reduce our business and strategic flexibility, increase our interest expense, limit the success of our deleveraging efforts, and impact changes to our credit ratings, which could increase our interest expense in the event of additional downgrades; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; additional impairment of goodwill or intangible assets; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, AI-related vulnerabilities, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of fire, flood, hurricanes, other severe weather, natural disasters, other catastrophic events, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties, treaties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; changes in currency exchange rates and interest rates; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.
Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
Presentation
This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.
Use of Non-US GAAP Financial Information
This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for operating EBITDA margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.
Definitions of Non-US GAAP Financial Measures
Reconciliation of Non-US GAAP Financial Measures
Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about August 4, 2026 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Beginning with the reporting period ending June 30, 2026, the Company revised its presentation of Equity Earnings and Dividend Income Attributable to Celanese Corporation. Previously, Other Income (Expense) Attributable to Celanese Corporation was included with the presentation of Equity Earnings and Dividend Income Attributable to Celanese Corporation. To provide a better understanding for readers of the U.S. GAAP results of the Company’s non-consolidated equity investments by presenting such results in isolation and better align with how management assesses such results, Other Income (Expense) Attributable to Celanese Corporation is now included with Non-Operating Pension, Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation. Prior periods presented have been revised to reflect this change.
Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending June 30, 2026.
Supplemental Information
Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.
|
Consolidated Statements of Operations - Unaudited |
|||||||||||
|
Three Months Ended |
||||||||||
|
June 30,
|
|
March 31,
|
|
June 30,
|
||||||
|
(In $ millions, except share and per share data) |
||||||||||
Net sales |
2,752 |
|
|
2,337 |
|
|
2,532 |
|
|||
Cost of sales |
|
(2,134 |
) |
|
|
(1,869 |
) |
|
|
(1,998 |
) |
Gross profit |
|
618 |
|
|
|
468 |
|
|
|
534 |
|
Selling, general and administrative expenses |
|
(251 |
) |
|
|
(226 |
) |
|
|
(214 |
) |
Amortization of intangible assets |
|
(39 |
) |
|
|
(40 |
) |
|
|
(42 |
) |
Research and development expenses |
|
(29 |
) |
|
|
(28 |
) |
|
|
(31 |
) |
Other (charges) gains, net |
|
(31 |
) |
|
|
(20 |
) |
|
|
(20 |
) |
Foreign exchange gain (loss), net |
|
10 |
|
|
|
12 |
|
|
|
6 |
|
Gain (loss) on disposition of businesses and assets, net |
|
(2 |
) |
|
|
48 |
|
|
|
(2 |
) |
Operating profit (loss) |
|
276 |
|
|
|
214 |
|
|
|
231 |
|
Equity in net earnings (loss) of affiliates |
|
11 |
|
|
|
35 |
|
|
|
29 |
|
Non-operating pension and other postretirement employee benefit (expense) income |
|
5 |
|
|
|
5 |
|
|
|
1 |
|
Interest expense |
|
(186 |
) |
|
|
(183 |
) |
|
|
(177 |
) |
Interest income |
|
10 |
|
|
|
9 |
|
|
|
7 |
|
Dividend income - equity investments |
|
43 |
|
|
|
1 |
|
|
|
41 |
|
Other income (expense), net |
|
(17 |
) |
|
|
1 |
|
|
|
1 |
|
Earnings (loss) from continuing operations before tax |
|
142 |
|
|
|
82 |
|
|
|
133 |
|
Income tax (provision) benefit |
|
(11 |
) |
|
|
(33 |
) |
|
|
77 |
|
Earnings (loss) from continuing operations |
|
131 |
|
|
|
49 |
|
|
|
210 |
|
Earnings (loss) from operation of discontinued operations |
|
(2 |
) |
|
|
(1 |
) |
|
|
(10 |
) |
Income tax (provision) benefit from discontinued operations |
|
— |
|
|
|
— |
|
|
|
— |
|
Earnings (loss) from discontinued operations |
|
(2 |
) |
|
|
(1 |
) |
|
|
(10 |
) |
Net earnings (loss) |
|
129 |
|
|
|
48 |
|
|
|
200 |
|
Net (earnings) loss attributable to noncontrolling interests |
|
(4 |
) |
|
|
(4 |
) |
|
|
(3 |
) |
Net earnings (loss) attributable to Celanese Corporation |
|
125 |
|
|
|
44 |
|
|
|
197 |
|
Amounts attributable to Celanese Corporation |
|
|
|
|
|
||||||
Earnings (loss) from continuing operations |
|
127 |
|
|
|
45 |
|
|
|
207 |
|
Earnings (loss) from discontinued operations |
|
(2 |
) |
|
|
(1 |
) |
|
|
(10 |
) |
Net earnings (loss) |
|
125 |
|
|
|
44 |
|
|
|
197 |
|
Earnings (loss) per common share - basic |
|
|
|
|
|
||||||
Continuing operations |
|
1.16 |
|
|
|
0.41 |
|
|
|
1.89 |
|
Discontinued operations |
|
(0.02 |
) |
|
|
(0.01 |
) |
|
|
(0.09 |
) |
Net earnings (loss) - basic |
|
1.14 |
|
|
|
0.40 |
|
|
|
1.80 |
|
Earnings (loss) per common share - diluted |
|
|
|
|
|
||||||
Continuing operations |
|
1.15 |
|
|
|
0.41 |
|
|
|
1.89 |
|
Discontinued operations |
|
(0.02 |
) |
|
|
(0.01 |
) |
|
|
(0.09 |
) |
Net earnings (loss) - diluted |
|
1.13 |
|
|
|
0.40 |
|
|
|
1.80 |
|
Weighted average shares (in millions) |
|
|
|
|
|
||||||
Basic |
|
109.8 |
|
|
|
109.7 |
|
|
|
109.5 |
|
Diluted |
|
110.2 |
|
|
|
110.0 |
|
|
|
109.7 |
|
Consolidated Balance Sheets - Unaudited |
|||||
|
As of June 30, 2026 |
|
As of December 31, 2025 |
||
|
|||||
|
(In $ millions) |
||||
ASSETS |
|
|
|
||
Current Assets |
|
|
|
||
Cash and cash equivalents |
1,364 |
|
|
1,263 |
|
Trade receivables - third party and affiliates, net |
1,288 |
|
|
922 |
|
Non-trade receivables, net |
581 |
|
|
545 |
|
Inventories |
2,305 |
|
|
2,220 |
|
Assets held for sale |
— |
|
|
492 |
|
Other assets |
257 |
|
|
251 |
|
Total current assets |
5,795 |
|
|
5,693 |
|
Investments in affiliates |
1,233 |
|
|
1,252 |
|
Property, plant and equipment, net |
4,807 |
|
|
5,076 |
|
Operating lease right-of-use assets |
417 |
|
|
359 |
|
Deferred income taxes |
1,325 |
|
|
1,359 |
|
Other assets |
605 |
|
|
601 |
|
Goodwill |
4,151 |
|
|
4,171 |
|
Intangible assets, net |
3,075 |
|
|
3,184 |
|
Total assets |
21,408 |
|
|
21,695 |
|
LIABILITIES AND EQUITY |
|
|
|
||
Current Liabilities |
|
|
|
||
Short-term borrowings and current installments of long-term debt - third party and affiliates |
1,311 |
|
|
1,204 |
|
Trade payables - third party and affiliates |
1,485 |
|
|
1,279 |
|
Liabilities held for sale |
— |
|
|
75 |
|
Other liabilities |
1,106 |
|
|
1,049 |
|
Income taxes payable |
104 |
|
|
76 |
|
Total current liabilities |
4,006 |
|
|
3,683 |
|
Long-term debt, net of unamortized deferred financing costs |
10,696 |
|
|
11,394 |
|
Deferred income taxes |
458 |
|
|
512 |
|
Uncertain tax positions |
211 |
|
|
208 |
|
Benefit obligations |
321 |
|
|
344 |
|
Operating lease liabilities |
317 |
|
|
265 |
|
Other liabilities |
811 |
|
|
817 |
|
Commitments and Contingencies |
|
|
|
||
Shareholders' Equity |
|
|
|
||
Treasury stock, at cost |
(5,480 |
) |
|
(5,482 |
) |
Additional paid-in capital |
450 |
|
|
431 |
|
Retained earnings |
10,039 |
|
|
9,876 |
|
Accumulated other comprehensive income (loss), net |
(842 |
) |
|
(776 |
) |
Total Celanese Corporation shareholders' equity |
4,167 |
|
|
4,049 |
|
Noncontrolling interests |
421 |
|
|
423 |
|
Total equity |
4,588 |
|
|
4,472 |
|
Total liabilities and equity |
21,408 |
|
|
21,695 |
|
Non-U.S. GAAP Financial Measures and Supplemental Information
August 4, 2026
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-U.S. GAAP financial measures. This document is updated quarterly.
Presentation
This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.
Use of Non-U.S. GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with U.S. GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable U.S. GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other U.S. GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity.
Definitions
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Beginning with the reporting period ending June 30, 2026, the Company revised its presentation of Equity Earnings and Dividend Income Attributable to Celanese Corporation. Previously, Other Income (Expense) Attributable to Celanese Corporation was included with the presentation of Equity Earnings and Dividend Income Attributable to Celanese Corporation. To provide a better understanding for readers of the U.S. GAAP results of the Company’s non-consolidated equity investments by presenting such results in isolation and better align with how management assesses such results, Other Income (Expense) Attributable to Celanese Corporation is now included with Non-Operating Pension, Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation. Prior periods presented have been revised to reflect this change.
Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending June 30, 2026.
Table 1 Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited |
||||||||||||||||||||
|
||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||
|
(In $ millions) |
|||||||||||||||||||
Net earnings (loss) attributable to Celanese Corporation |
125 |
|
|
44 |
|
|
(1,165 |
) |
|
19 |
|
|
(1,357 |
) |
|
197 |
|
|
(24 |
) |
(Earnings) loss from discontinued operations |
2 |
|
|
1 |
|
|
21 |
|
|
6 |
|
|
— |
|
|
10 |
|
|
5 |
|
Interest income |
(10 |
) |
|
(9 |
) |
|
(24 |
) |
|
(6 |
) |
|
(7 |
) |
|
(7 |
) |
|
(4 |
) |
Interest expense |
186 |
|
|
183 |
|
|
701 |
|
|
177 |
|
|
177 |
|
|
177 |
|
|
170 |
|
Refinancing expense |
— |
|
|
— |
|
|
68 |
|
|
36 |
|
|
— |
|
|
— |
|
|
32 |
|
Income tax provision (benefit) |
11 |
|
|
33 |
|
|
(90 |
) |
|
(15 |
) |
|
(7 |
) |
|
(77 |
) |
|
9 |
|
Certain Items attributable to Celanese Corporation (Table 8) |
156 |
|
|
23 |
|
|
1,639 |
|
|
34 |
|
|
1,520 |
|
|
42 |
|
|
43 |
|
Adjusted EBIT |
470 |
|
|
275 |
|
|
1,150 |
|
|
251 |
|
|
326 |
|
|
342 |
|
|
231 |
|
Depreciation and amortization expense(1) |
179 |
|
|
180 |
|
|
743 |
|
|
184 |
|
|
191 |
|
|
188 |
|
|
180 |
|
Operating EBITDA |
649 |
|
|
455 |
|
|
1,893 |
|
|
435 |
|
|
517 |
|
|
530 |
|
|
411 |
|
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|
(In $ millions) |
||||||||||||
Engineered Materials |
43 |
|
3 |
|
6 |
|
1 |
|
3 |
|
2 |
|
— |
Acetyl Chain |
22 |
|
18 |
|
11 |
|
11 |
|
— |
|
— |
|
— |
Other Activities(2) |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
Accelerated depreciation and amortization expense |
65 |
|
21 |
|
17 |
|
12 |
|
3 |
|
2 |
|
— |
Depreciation and amortization expense(1) |
179 |
|
180 |
|
743 |
|
184 |
|
191 |
|
188 |
|
180 |
Total depreciation and amortization expense |
244 |
|
201 |
|
760 |
|
196 |
|
194 |
|
190 |
|
180 |
_________________________ |
|
| (1) | Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above. |
| (2) | Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 2 Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited |
|||||||||||||||||||||||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||||||||||||||||||||||||
|
(In $ millions, except percentages) |
||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin |
|||||||||||||||||||||||||||||||||||||||||
Engineered Materials |
156 |
|
|
10.8 |
% |
|
221 |
|
|
16.7 |
% |
|
(958 |
) |
|
(17.8 |
)% |
|
111 |
|
|
8.7 |
% |
|
(1,327 |
) |
|
(95.9 |
)% |
|
164 |
|
|
11.4 |
% |
|
94 |
|
|
7.3 |
% |
Acetyl Chain |
237 |
|
|
17.8 |
% |
|
95 |
|
|
9.2 |
% |
|
539 |
|
|
12.7 |
% |
|
90 |
|
|
9.6 |
% |
|
135 |
|
|
12.7 |
% |
|
153 |
|
|
13.7 |
% |
|
161 |
|
|
14.4 |
% |
Other Activities(1) |
(117 |
) |
|
|
|
(102 |
) |
|
|
|
(367 |
) |
|
|
|
(108 |
) |
|
|
|
(83 |
) |
|
|
|
(86 |
) |
|
|
|
(90 |
) |
|
|
|||||||
Total |
276 |
|
|
10.0 |
% |
|
214 |
|
|
9.2 |
% |
|
(786 |
) |
|
(8.2 |
)% |
|
93 |
|
|
4.2 |
% |
|
(1,275 |
) |
|
(52.7 |
)% |
|
231 |
|
|
9.1 |
% |
|
165 |
|
|
6.9 |
% |
Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials |
2 |
|
|
|
|
2 |
|
|
|
|
6 |
|
|
|
|
— |
|
|
|
|
3 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
|||||||
Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain |
2 |
|
|
|
|
2 |
|
|
|
|
8 |
|
|
|
|
3 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
|
2 |
|
|
|
|||||||
Operating Profit (Loss) Attributable to Celanese Corporation |
272 |
|
|
9.9 |
% |
|
210 |
|
|
9.0 |
% |
|
(800 |
) |
|
(8.4 |
)% |
|
90 |
|
|
4.1 |
% |
|
(1,279 |
) |
|
(52.9 |
)% |
|
228 |
|
|
9.0 |
% |
|
161 |
|
|
6.7 |
% |
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation |
|||||||||||||||||||||||||||||||||||||||||
Engineered Materials |
154 |
|
|
10.7 |
% |
|
219 |
|
|
16.5 |
% |
|
(964 |
) |
|
(17.9 |
)% |
|
111 |
|
|
8.7 |
% |
|
(1,330 |
) |
|
(96.1 |
)% |
|
163 |
|
|
11.3 |
% |
|
92 |
|
|
7.1 |
% |
Acetyl Chain |
235 |
|
|
17.7 |
% |
|
93 |
|
|
9.0 |
% |
|
531 |
|
|
12.5 |
% |
|
87 |
|
|
9.3 |
% |
|
134 |
|
|
12.6 |
% |
|
151 |
|
|
13.5 |
% |
|
159 |
|
|
14.2 |
% |
Other Activities(1) |
(117 |
) |
|
|
|
(102 |
) |
|
|
|
(367 |
) |
|
|
|
(108 |
) |
|
|
|
(83 |
) |
|
|
|
(86 |
) |
|
|
|
(90 |
) |
|
|
|||||||
Total |
272 |
|
|
9.9 |
% |
|
210 |
|
|
9.0 |
% |
|
(800 |
) |
|
(8.4 |
)% |
|
90 |
|
|
4.1 |
% |
|
(1,279 |
) |
|
(52.9 |
)% |
|
228 |
|
|
9.0 |
% |
|
161 |
|
|
6.7 |
% |
Equity Earnings and Dividend Income Attributable to Celanese Corporation |
|||||||||||||||||||||||||||||||||||||||||
Engineered Materials |
6 |
|
(2) |
|
|
31 |
|
|
|
|
105 |
|
|
|
|
32 |
|
|
|
|
33 |
|
|
|
|
24 |
|
|
|
|
16 |
|
|
|
|||||||
Acetyl Chain |
44 |
|
|
|
|
2 |
|
|
|
|
131 |
|
|
|
|
42 |
|
|
|
|
43 |
|
|
|
|
43 |
|
|
|
|
3 |
|
|
|
|||||||
Other Activities(1) |
4 |
|
|
|
|
3 |
|
|
|
|
13 |
|
|
|
|
3 |
|
|
|
|
3 |
|
|
|
|
3 |
|
|
|
|
4 |
|
|
|
|||||||
Total |
54 |
|
|
|
|
36 |
|
|
|
|
249 |
|
|
|
|
77 |
|
|
|
|
79 |
|
|
|
|
70 |
|
|
|
|
23 |
|
|
|
|||||||
Non-Operating Pension, Other Post-Retirement Employee Benefit and Other Income (Expense) Attributable to Celanese Corporation |
|||||||||||||||||||||||||||||||||||||||||
Engineered Materials |
(16 |
) |
|
|
|
1 |
|
|
|
|
7 |
|
|
|
|
3 |
|
|
|
|
2 |
|
|
|
|
1 |
|
|
|
|
1 |
|
|
|
|||||||
Acetyl Chain |
— |
|
|
|
|
— |
|
|
|
|
1 |
|
|
|
|
— |
|
|
|
|
1 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|||||||
Other Activities(1) |
4 |
|
|
|
|
5 |
|
|
|
|
54 |
|
|
|
|
47 |
|
|
|
|
3 |
|
|
|
|
1 |
|
|
|
|
3 |
|
|
|
|||||||
Total |
(12 |
) |
|
|
|
6 |
|
|
|
|
62 |
|
|
|
|
50 |
|
|
|
|
6 |
|
|
|
|
2 |
|
|
|
|
4 |
|
|
|
|||||||
Certain Items Attributable to Celanese Corporation (Table 8) |
|||||||||||||||||||||||||||||||||||||||||
Engineered Materials |
90 |
|
|
|
|
(31 |
) |
|
|
|
1,572 |
|
|
|
|
37 |
|
|
|
|
1,495 |
|
|
|
|
25 |
|
|
|
|
15 |
|
|
|
|||||||
Acetyl Chain |
42 |
|
|
|
|
36 |
|
|
|
|
32 |
|
|
|
|
17 |
|
|
|
|
9 |
|
|
|
|
1 |
|
|
|
|
5 |
|
|
|
|||||||
Other Activities(1) |
24 |
|
|
|
|
18 |
|
|
|
|
35 |
|
|
|
|
(20 |
) |
|
|
|
16 |
|
|
|
|
16 |
|
|
|
|
23 |
|
|
|
|||||||
Total |
156 |
|
|
|
|
23 |
|
|
|
|
1,639 |
|
|
|
|
34 |
|
|
|
|
1,520 |
|
|
|
|
42 |
|
|
|
|
43 |
|
|
|
|||||||
Adjusted EBIT / Adjusted EBIT Margin |
|||||||||||||||||||||||||||||||||||||||||
Engineered Materials |
234 |
|
|
16.2 |
% |
|
220 |
|
|
16.6 |
% |
|
720 |
|
|
13.4 |
% |
|
183 |
|
|
14.3 |
% |
|
200 |
|
|
14.5 |
% |
|
213 |
|
|
14.8 |
% |
|
124 |
|
|
9.6 |
% |
Acetyl Chain |
321 |
|
|
24.2 |
% |
|
131 |
|
|
12.6 |
% |
|
695 |
|
|
16.4 |
% |
|
146 |
|
|
15.5 |
% |
|
187 |
|
|
17.6 |
% |
|
195 |
|
|
17.5 |
% |
|
167 |
|
|
15.0 |
% |
Other Activities(1) |
(85 |
) |
|
|
|
(76 |
) |
|
|
|
(265 |
) |
|
|
|
(78 |
) |
|
|
|
(61 |
) |
|
|
|
(66 |
) |
|
|
|
(60 |
) |
|
|
|||||||
Total |
470 |
|
|
17.1 |
% |
|
275 |
|
|
11.8 |
% |
|
1,150 |
|
|
12.0 |
% |
|
251 |
|
|
11.4 |
% |
|
326 |
|
|
13.5 |
% |
|
342 |
|
|
13.5 |
% |
|
231 |
|
|
9.7 |
% |
________________________ |
|
(1) |
Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
(2) |
Includes $14 million of restructuring activities at our Mylar Specialty Films strategic affiliate, which are also included in Certain Items (see Table 8). |
Table 2 Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.) |
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||||||||||||||||||||||||
|
(In $ millions, except percentages) |
||||||||||||||||||||||||||||||||||||||||
Depreciation and Amortization Expense(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Engineered Materials |
101 |
|
|
|
|
104 |
|
|
|
|
441 |
|
|
|
|
105 |
|
|
|
|
115 |
|
|
|
|
112 |
|
|
|
|
109 |
|
|
|
|||||||
Acetyl Chain |
64 |
|
|
|
|
63 |
|
|
|
|
252 |
|
|
|
|
64 |
|
|
|
|
63 |
|
|
|
|
64 |
|
|
|
|
61 |
|
|
|
|||||||
Other Activities(2) |
14 |
|
|
|
|
13 |
|
|
|
|
50 |
|
|
|
|
15 |
|
|
|
|
13 |
|
|
|
|
12 |
|
|
|
|
10 |
|
|
|
|||||||
Total |
179 |
|
|
|
|
180 |
|
|
|
|
743 |
|
|
|
|
184 |
|
|
|
|
191 |
|
|
|
|
188 |
|
|
|
|
180 |
|
|
|
|||||||
Operating EBITDA / Operating EBITDA Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Engineered Materials |
335 |
|
|
23.2 |
% |
|
324 |
|
|
24.5 |
% |
|
1,161 |
|
|
21.5 |
% |
|
288 |
|
|
22.6 |
% |
|
315 |
|
|
22.8 |
% |
|
325 |
|
|
22.5 |
% |
|
233 |
|
|
18.1 |
% |
Acetyl Chain |
385 |
|
|
29.0 |
% |
|
194 |
|
|
18.7 |
% |
|
947 |
|
|
22.4 |
% |
|
210 |
|
|
22.3 |
% |
|
250 |
|
|
23.6 |
% |
|
259 |
|
|
23.2 |
% |
|
228 |
|
|
20.4 |
% |
Other Activities(2) |
(71 |
) |
|
|
|
(63 |
) |
|
|
|
(215 |
) |
|
|
|
(63 |
) |
|
|
|
(48 |
) |
|
|
|
(54 |
) |
|
|
|
(50 |
) |
|
|
|||||||
Total |
649 |
|
|
23.6 |
% |
|
455 |
|
|
19.5 |
% |
|
1,893 |
|
|
19.8 |
% |
|
435 |
|
|
19.7 |
% |
|
517 |
|
|
21.4 |
% |
|
530 |
|
|
20.9 |
% |
|
411 |
|
|
17.2 |
% |
_________________________ |
|
| (1) | Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details. |
| (2) | Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 3 Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited |
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||||||||||||||||||||
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
||||||||||
|
(In $ millions, except per share data) |
||||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations attributable to Celanese Corporation |
127 |
|
|
1.15 |
|
45 |
|
|
0.41 |
|
(1,144 |
) |
|
(10.44 |
) |
|
25 |
|
|
0.23 |
|
(1,357 |
) |
|
(12.39 |
) |
|
207 |
|
|
1.89 |
|
(19 |
) |
|
(0.17 |
) |
Income tax provision (benefit) |
11 |
|
|
|
|
33 |
|
|
|
|
(90 |
) |
|
|
|
(15 |
) |
|
|
|
(7 |
) |
|
|
|
(77 |
) |
|
|
|
9 |
|
|
|
|||
Earnings (loss) from continuing operations before tax |
138 |
|
|
|
|
78 |
|
|
|
|
(1,234 |
) |
|
|
|
10 |
|
|
|
|
(1,364 |
) |
|
|
|
130 |
|
|
|
|
(10 |
) |
|
|
|||
Certain Items attributable to Celanese Corporation (Table 8) |
156 |
|
|
|
|
23 |
|
|
|
|
1,639 |
|
|
|
|
34 |
|
|
|
|
1,520 |
|
|
|
|
42 |
|
|
|
|
43 |
|
|
|
|||
Refinancing and related expenses |
— |
|
|
|
— |
|
|
|
68 |
|
|
|
|
36 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
32 |
|
|
|
|||||
Adjusted earnings (loss) from continuing operations before tax |
294 |
|
|
|
|
101 |
|
|
|
|
473 |
|
|
|
|
80 |
|
|
|
|
156 |
|
|
|
|
172 |
|
|
|
|
65 |
|
|
|
|||
Income tax (provision) benefit on adjusted earnings(1) |
(24 |
) |
|
|
|
(8 |
) |
|
|
|
(36 |
) |
|
|
|
(6 |
) |
|
|
|
(9 |
) |
|
|
|
(15 |
) |
|
|
|
(6 |
) |
|
|
|||
Adjusted earnings (loss) from continuing operations(2) |
270 |
|
|
2.45 |
|
93 |
|
|
0.85 |
|
437 |
|
|
3.98 |
|
|
74 |
|
|
0.67 |
|
147 |
|
|
1.34 |
|
|
157 |
|
|
1.43 |
|
59 |
|
|
0.54 |
|
|
Diluted shares (in millions)(3) |
||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding |
109.8 |
|
|
|
|
109.7 |
|
|
|
|
109.5 |
|
|
|
|
109.6 |
|
|
|
|
109.6 |
|
|
|
|
109.5 |
|
|
|
|
109.4 |
|
|
|
|||
Incremental shares attributable to equity awards |
0.4 |
|
|
|
|
0.3 |
|
|
|
|
0.2 |
|
|
|
|
0.2 |
|
|
|
|
— |
|
|
|
|
0.2 |
|
|
|
|
— |
|
|
|
|||
Total diluted shares |
110.2 |
|
|
|
|
110.0 |
|
|
|
|
109.7 |
|
|
|
|
109.8 |
|
|
|
|
109.6 |
|
|
|
|
109.7 |
|
|
|
|
109.4 |
|
|
|
|||
_______________________________ |
|
| (1) | Calculated using adjusted effective tax rates (Table 3a) as follows: |
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|||||||||||||||
|
|
|||||||||||||||||||||||||||
Adjusted effective tax rate |
8 |
|
|
|
8 |
|
|
|
8 |
|
|
|
8 |
|
|
|
6 |
|
|
|
9 |
|
|
|
9 |
|
|
|
| (2) | Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns. |
|
|
Actual Plan
|
|
Expected
|
||
|
|
(In percentages) |
||||
2025 |
|
7.8 |
|
5.3 |
||
| (3) | Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive. |
Table 3a Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited |
|||||
|
|||||
|
Estimated |
|
Actual |
||
|
2026 |
|
2025 |
||
|
(In percentages) |
||||
U.S. GAAP annual effective tax rate |
21 |
|
|
7 |
|
Discrete quarterly recognition of GAAP items(1) |
(2 |
) |
|
17 |
|
Tax impact of other charges and adjustments(2) |
(3 |
) |
|
(12 |
) |
Utilization of foreign tax credits |
(5 |
) |
|
— |
|
Changes in valuation allowances, excluding impact of other charges and adjustments(3) |
2 |
|
|
(12 |
) |
Other, includes effect of discrete current year transactions(4) |
(5 |
) |
|
8 |
|
Adjusted tax rate |
8 |
|
|
8 |
|
____________________ |
|
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results. |
|
| (1) | Such as changes in tax laws (including U.S. tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments. |
| (2) | Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes. |
| (3) | Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments. |
| (4) | Includes tax impacts related to full-year actual tax opportunities and related costs, as well as current year realization of U.S. GAAP benefits deferred in prior years. |
Table 4 Net Sales by Segment - Unaudited |
||||||||||||||||||||
|
||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|||||||
|
(In $ millions) |
|||||||||||||||||||
Engineered Materials |
1,446 |
|
|
1,325 |
|
|
5,390 |
|
|
1,277 |
|
|
1,384 |
|
|
1,442 |
|
|
1,287 |
|
Acetyl Chain |
1,329 |
|
|
1,036 |
|
|
4,232 |
|
|
940 |
|
|
1,061 |
|
|
1,115 |
|
|
1,116 |
|
Intersegment eliminations(1) |
(23 |
) |
|
(24 |
) |
|
(78 |
) |
|
(13 |
) |
|
(26 |
) |
|
(25 |
) |
|
(14 |
) |
Net sales |
2,752 |
|
|
2,337 |
|
|
9,544 |
|
|
2,204 |
|
|
2,419 |
|
|
2,532 |
|
|
2,389 |
|
____________________________ |
|
| (1) | Includes intersegment sales primarily related to the Acetyl Chain. |
Table 4a Factors Affecting Segment Net Sales Sequentially - Unaudited
Three Months Ended June 30, 2026 Compared to Three Months Ended March 31, 2026 |
||||||||
|
||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|
(In percentages) |
|
||||||
Engineered Materials |
3 |
|
6 |
|
— |
|
9 |
(1) |
Acetyl Chain |
6 |
|
22 |
|
— |
|
28 |
|
|
|
|
|
|
|
|
|
|
Total Company |
4 |
|
14 |
|
— |
|
18 |
|
Three Months Ended March 31, 2026 Compared to Three Months Ended December 31, 2025 |
||||||||
|
||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|
(In percentages) |
|
||||||
Engineered Materials |
3 |
|
— |
|
1 |
|
4 |
|
Acetyl Chain |
8 |
|
1 |
|
1 |
|
10 |
|
|
|
|
|
|
|
|
|
|
Total Company |
5 |
|
— |
|
1 |
|
6 |
|
Three Months Ended December 31, 2025 Compared to Three Months Ended September 30, 2025 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
(6 |
) |
|
(2 |
) |
|
— |
|
(8 |
) |
|
Acetyl Chain |
(10 |
) |
|
(1 |
) |
|
— |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Company |
(7 |
) |
|
(2 |
) |
|
— |
|
(9 |
) |
|
Three Months Ended September 30, 2025 Compared to Three Months Ended June 30, 2025 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
(6 |
) |
|
1 |
|
|
1 |
|
(4 |
) |
|
Acetyl Chain |
(2 |
) |
|
(4 |
) |
|
1 |
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Company |
(4 |
) |
|
(1 |
) |
|
1 |
|
(4 |
) |
|
Three Months Ended June 30, 2025 Compared to Three Months Ended March 31, 2025 |
||||||||||
|
||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
||
|
(In percentages) |
|
||||||||
Engineered Materials |
9 |
|
|
— |
|
|
3 |
|
12 |
|
Acetyl Chain |
(1 |
) |
|
(2 |
) |
|
3 |
|
— |
|
|
|
|
|
|
|
|
|
|
||
Total Company |
4 |
|
|
(1 |
) |
|
3 |
|
6 |
|
Three Months Ended March 31, 2025 Compared to Three Months Ended December 31, 2024 |
||||||||||
|
||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
||
|
(In percentages) |
|
||||||||
Engineered Materials |
— |
|
2 |
|
|
(1 |
) |
|
1 |
|
Acetyl Chain |
3 |
|
(1 |
) |
|
(1 |
) |
|
1 |
|
|
|
|
|
|
|
|
|
|
||
Total Company |
2 |
|
— |
|
|
(1 |
) |
|
1 |
|
_______________________________ |
|
(1) |
Includes a (4), 0, and 0 percent net sales impact of volume, price, and currency, respectively, as a result of the sale of the Micromax® business. |
| Table 4b
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Three Months Ended June 30, 2026 Compared to Three Months Ended June 30, 2025 |
|||||||||
|
|||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|
|
(In percentages) |
|
|||||||
Engineered Materials |
(6 |
) |
|
5 |
|
1 |
|
— |
(1) |
Acetyl Chain |
— |
|
|
18 |
|
1 |
|
19 |
|
|
|
|
|
|
|
|
|
|
|
Total Company |
(3 |
) |
|
11 |
|
1 |
|
9 |
|
Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
— |
|
|
(1 |
) |
|
4 |
|
3 |
|
|
Acetyl Chain |
(7 |
) |
|
(4 |
) |
|
4 |
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Company |
(3 |
) |
|
(3 |
) |
|
4 |
|
(2 |
) |
|
Three Months Ended December 31, 2025 Compared to Three Months Ended December 31, 2024 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
(2 |
) |
|
— |
|
|
3 |
|
1 |
|
|
Acetyl Chain |
(10 |
) |
|
(7 |
) |
|
2 |
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Company |
(6 |
) |
|
(3 |
) |
|
2 |
|
(7 |
) |
|
Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
(8 |
) |
|
(1 |
) |
|
2 |
|
(7 |
) |
|
Acetyl Chain |
(4 |
) |
|
(8 |
) |
|
1 |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Company |
(6 |
) |
|
(4 |
) |
|
1 |
|
(9 |
) |
|
Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
(3 |
) |
|
(1 |
) |
|
2 |
|
(2 |
) |
|
Acetyl Chain |
(2 |
) |
|
(7 |
) |
|
2 |
|
(7 |
) |
|
|
|
|
|
|
|
|
|
||||
Total Company |
(2 |
) |
|
(4 |
) |
|
2 |
|
(4 |
) |
|
Three Months Ended March 31, 2025 Compared to Three Months Ended March 31, 2024 |
||||||||||||
|
||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
||||
|
(In percentages) |
|
||||||||||
Engineered Materials |
(4 |
) |
|
(2 |
) |
|
(1 |
) |
|
(7 |
) |
|
Acetyl Chain |
(6 |
) |
|
(4 |
) |
|
(1 |
) |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|||||
Total Company |
(5 |
) |
|
(3 |
) |
|
(1 |
) |
|
(9 |
) |
|
____________________ |
|
(1) |
Includes a (6), 0, and 0 percent net sales impact of volume, price, and currency, respectively, as a result of the sale of the Micromax® business. |
| Table 4c
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Year Ended December 31, 2025 Compared to Year Ended December 31, 2024 |
|||||||||||
|
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
|
|||
|
(In percentages) |
|
|||||||||
Engineered Materials |
(4 |
) |
|
(1 |
) |
|
1 |
|
(4 |
) |
|
Acetyl Chain |
(6 |
) |
|
(6 |
) |
|
1 |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Company |
(4 |
) |
|
(4 |
) |
|
1 |
|
(7 |
) |
|
| Table 5
Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited |
||||||||||||||||||||
|
||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|||||||
|
(In $ millions, except percentages) |
|||||||||||||||||||
Net cash provided by (used in) investing activities |
(59 |
) |
|
425 |
|
|
(349 |
) |
|
(104 |
) |
|
(59 |
) |
|
(88 |
) |
|
(98 |
) |
Net cash provided by (used in) financing activities |
(546 |
) |
|
(3 |
) |
|
(513 |
) |
|
(324 |
) |
|
(118 |
) |
|
(116 |
) |
|
45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net cash provided by (used in) operating activities |
209 |
|
|
76 |
|
|
1,146 |
|
|
252 |
|
|
447 |
|
|
410 |
|
|
37 |
|
Capital expenditures on property, plant and equipment |
(62 |
) |
|
(66 |
) |
|
(343 |
) |
|
(84 |
) |
|
(64 |
) |
|
(93 |
) |
|
(102 |
) |
Contributions from/(Distributions) to NCI |
(7 |
) |
|
(7 |
) |
|
(30 |
) |
|
(8 |
) |
|
(8 |
) |
|
(6 |
) |
|
(8 |
) |
Free cash flow(1) |
140 |
|
|
3 |
|
|
773 |
|
|
160 |
|
|
375 |
|
|
311 |
|
|
(73 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net sales |
2,752 |
|
|
2,337 |
|
|
9,544 |
|
|
2,204 |
|
|
2,419 |
|
|
2,532 |
|
|
2,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Free cash flow as % of Net sales |
5.1 |
% |
|
0.1 |
% |
|
8.1 |
% |
|
7.3 |
% |
|
15.5 |
% |
|
12.3 |
% |
|
(3.1 |
)% |
_______________________________ |
|
| (1) | Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures. |
Table 6 Cash Dividends Received - Unaudited |
|||||||||||||
|
|||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|
(In $ millions) |
||||||||||||
Dividends from equity method investments |
16 |
|
54 |
|
139 |
|
47 |
|
40 |
|
21 |
|
31 |
Dividends from equity investments without readily determinable fair values |
43 |
|
1 |
|
122 |
|
40 |
|
40 |
|
41 |
|
1 |
Total |
59 |
|
55 |
|
261 |
|
87 |
|
80 |
|
62 |
|
32 |
Table 7 Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited |
||||||||||||||||||||
|
||||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|||||||
|
(In $ millions) |
|||||||||||||||||||
Short-term borrowings and current installments of long-term debt - third party and affiliates |
1,311 |
|
|
1,741 |
|
|
1,204 |
|
|
1,204 |
|
|
1,199 |
|
|
252 |
|
|
406 |
|
Long-term debt, net of unamortized deferred financing costs |
10,696 |
|
|
10,813 |
|
|
11,394 |
|
|
11,394 |
|
|
11,655 |
|
|
12,689 |
|
|
12,378 |
|
Total debt |
12,007 |
|
|
12,554 |
|
|
12,598 |
|
|
12,598 |
|
|
12,854 |
|
|
12,941 |
|
|
12,784 |
|
Cash and cash equivalents |
(1,364 |
) |
|
(1,758 |
) |
|
(1,263 |
) |
|
(1,263 |
) |
|
(1,440 |
) |
|
(1,173 |
) |
|
(951 |
) |
Net debt |
10,643 |
|
|
10,796 |
|
|
11,335 |
|
|
11,335 |
|
|
11,414 |
|
|
11,768 |
|
|
11,833 |
|
Table 8 Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures: |
|||||||||||||||||||
|
|||||||||||||||||||
|
Q2 '26 |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|
Income Statement Classification |
||||
|
(In $ millions) |
|
|
||||||||||||||||
Exit and shutdown costs |
121 |
|
|
44 |
|
|
98 |
|
|
29 |
|
|
10 |
|
27 |
|
32 |
|
Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income |
Asset impairments |
— |
|
|
— |
|
|
1,513 |
|
|
27 |
|
(1) |
1,486 |
(2) |
— |
|
— |
|
Cost of sales / Other (charges) gains, net |
Impact from plant incidents and natural disasters |
— |
|
|
11 |
|
|
3 |
|
|
— |
|
|
— |
|
— |
|
3 |
|
Cost of sales |
Mergers, acquisitions and dispositions |
35 |
|
|
15 |
|
|
52 |
|
|
23 |
|
|
12 |
|
12 |
|
5 |
|
Cost of sales / SG&A |
Actuarial (gain) loss on pension and postretirement plans |
— |
|
|
— |
|
|
(49 |
) |
|
(49 |
) |
|
— |
|
— |
|
— |
|
Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income |
Legal settlements and commercial disputes |
4 |
|
|
3 |
|
|
17 |
|
|
1 |
|
|
11 |
|
2 |
|
3 |
|
Cost of sales / SG&A / Other (charges) gains, net |
(Gain) loss on disposition of businesses and assets |
(4 |
) |
|
(50 |
) |
|
— |
|
|
— |
|
|
— |
|
— |
|
— |
|
Gain (loss) on disposition of businesses and assets, net |
Other |
— |
|
|
— |
|
|
5 |
|
|
3 |
|
|
1 |
|
1 |
|
— |
|
Cost of sales / SG&A |
Certain Items attributable to Celanese Corporation |
156 |
|
|
23 |
|
|
1,639 |
|
|
34 |
|
|
1,520 |
|
42 |
|
43 |
|
|
___________________________ |
|
(1) |
Related to impairment of certain long-lived assets arising from unused parcels of property subsequently sold. |
(2) |
Related to impairment of goodwill and certain trade names, primarily Zytel®, arising from our annual goodwill and indefinite-lived intangible assets impairment tests. |
Table 9 Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited |
||||||
|
||||||
|
|
|
|
|
2025 |
|
|
|
|
|
|
(In $ millions, except percentages) |
|
Net earnings (loss) attributable to Celanese Corporation |
|
|
|
|
(1,165 |
) |
|
|
|
|
|
|
|
Adjusted EBIT (Table 1) |
|
|
|
|
1,150 |
|
Adjusted effective tax rate (Table 3a) |
|
|
|
|
8 |
% |
Adjusted EBIT tax effected |
|
|
|
|
1,058 |
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
Average |
|
|
(In $ millions, except percentages) |
|||||
Short-term borrowings and current installments of long-term debt - third parties and affiliates |
1,204 |
|
1,501 |
|
1,353 |
|
Long-term debt, net of unamortized deferred financing costs |
11,394 |
|
11,078 |
|
11,236 |
|
Celanese Corporation shareholders' equity |
4,049 |
|
5,129 |
|
4,589 |
|
Invested capital |
|
|
|
|
17,178 |
|
|
|
|
|
|
|
|
Return on invested capital (adjusted) |
|
|
|
|
6.2 |
% |
|
|
|
|
|
|
|
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital |
|
|
|
|
(6.8 |
)% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260730200927/en/
Investor Relations
Bill Cunningham
Phone: +1 302 772 5231
william.cunningham@celanese.com
Media - U.S.
Jamaison Schuler
Phone: +1 972 443 4400
media@celanese.com
Media - Europe
Petra Czugler
Phone: +49 69 45009 1206
petra.czugler@celanese.com
Media - Asia
Maria Xia
Phone: +86 21 3861 9368
maria.xia@celanese.com